Published:
October 15, 2019
Last Updated:
October 15, 2019
Services:
Chemicals More...
Priorities:
Achieving Sustainability More...
Topics:
Activities:
Investment
Further Reading
The Every Company raises $175 million in Series C funding to commercialize animal-free ingredients
News Commentary | December 14, 2021
The funding of Every, co‑led by McWin and existing investor Rage Capital, brings the company's total investments to $233 million, which will help the company expand its recently commercialized egg white protein and animal‑free pepsin and focus on R&D to grow its business‑to‑business ingredients ... Not part of subscription
Redefine Meat nets USD 135 million for 3D-printed plant-based meat
News Commentary | January 27, 2022
Led by Hanaco Ventures and Synthesis Capital, Redefine Meat's funding round will support the building of production lines in Israel and the Netherlands. This investment follows a USD 29 million round in early 2021, bringing its total funding to USD 180 million. The company’s 3D‑printed, plant‑based... Not part of subscription
Tate & Lyle moves to acquire chickpea producer Nutriati
News Commentary | May 05, 2022
Tate & Lyle announced the acquisition of chickpea ingredient producer Nutriati following its distribution agreement with the startup in 2021. This news is not surprising given the rising popularity of chickpea as an alternative protein ingredient. Other major players like Ingredion made an ... Not part of subscription
by Thomas Hayes
This comes within days of a $12.5 million Series A round for Wild Type. Future Meat Technologies and Wild Type now join the ranks of Mosa Meat, Aleph Farms, and Memphis Meats in reaching Series A stage in the cultivated meat space, with Memphis Meats rumored to be closing a $250 million Series B round soon. Future Meat now plans to expand its R&D efforts and build a pilot production facility by the end of 2020. It aims to introduce hybrid products combining both plant-based and cell-based meats in 2021, followed by 100% cell-based meats in 2022. This is in line with Lux's commercialization roadmap for the broader cellular agriculture space and underscores that plant-based and cell-based meats are not mutually exclusive development areas.
For the original news article, click here .